非ホジキンリンパ腫 ... - nagano-med.jrc.or.jp

1 Cancer 1975 38 1484-1493 Cancer 1979 43 417-425 2002 346 4 235- 2006 7 379-9180 1999 17 1 268-276 2010 377 42-51 BLOOD 1990 76 7 1293-1298 JCO 2008 26 2 204-210 Cancer Sci. 2010;101 12 2579-2585R-B Cancer 2010 116 106-116 JCO 2008 26 7 4473-JCO 1994 12 6 1169-1176 EPOCH Transfusion 2007;47 1447 JCO 2000;18(21) 3633-3642 BLOOD 2002 99(8) 2685 20 1915-1925 CEPP NEJM 2013;368(15) BLOOD 1990;76(7) 1293 JCO 1999;19(12) 3776-3785 199435{7}635-J Dermatol. 2005;32 204-209 Jpn. J Cancer Chomother. 2005;328129 1993-IVAM 1996 77 2302-2307 JCO 2007;25(22) 3244-MTX-HOPE Jpn. J Cancer ;34(6) 885-889 BLOOD 2008;112(4) 975-Leukemia & Lymphoma 2005;46(12) 1839-1841 Leukemia & Lymphoma 2009;50(2) 2007 25 34 { }434-440 2007 25 30 4730- 2000 18 17 3144-3150 2002 20 10 2453- 2009 27 31 5213-Cancer Sci.

2 2010;100 1 158-164 2/3 VIC / 2009 27(33)5594-5600 GCD R Leukemia & lymphoma 2010;51(8):1523-1529 Cladribine 7days) CODOX-M Burkitt IVAC Burkitt COP IVLBCL R-CHOP IVLBCL IVLBCL R-HDMTX IVLBCL MACOP-B B R-FCM SMILE NK/T THP-COP MTX-MCNU-PCZ PCNSL) MTX-MCNU-PCZ PCNSL) R-CEOP FR { DHAP GDP CHASE GEM Cladribine 5days) NK/T ICE C-1C-1 IC Lancet Oncol. 2011;12 468-CHOP R R C-1 ESHAP 1}